KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oscar Health (OSCR) Free Cash Flow (2020 - 2025)

Oscar Health (OSCR) has disclosed Free Cash Flow for 6 consecutive years, with $662.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Free Cash Flow rose 94.95% year-over-year to $662.8 million, compared with a TTM value of $1.1 billion through Dec 2025, up 11.38%, and an annual FY2025 reading of $1.1 billion, up 11.38% over the prior year.
  • Free Cash Flow was $662.8 million for Q4 2025 at Oscar Health, up from -$973.7 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at $869.5 million in Q1 2025 and bottomed at -$1.2 billion in Q3 2023.
  • Average Free Cash Flow over 5 years is $92.7 million, with a median of $249.6 million recorded in 2022.
  • The sharpest move saw Free Cash Flow plummeted 168.5% in 2021, then skyrocketed 428.96% in 2022.
  • Year by year, Free Cash Flow stood at $27.3 million in 2021, then surged by 428.96% to $144.3 million in 2022, then soared by 101.55% to $290.8 million in 2023, then rose by 16.93% to $340.0 million in 2024, then skyrocketed by 94.95% to $662.8 million in 2025.
  • Business Quant data shows Free Cash Flow for OSCR at $662.8 million in Q4 2025, -$973.7 million in Q3 2025, and $499.8 million in Q2 2025.